SOFT TISSUE SARCOMA (STS)
Clinical trials for SOFT TISSUE SARCOMA (STS) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (STS) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (STS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to fight rare sarcoma
Disease control Not yet recruitingThis Phase 2 trial tests two drugs, OVV-01 and AK112, given together every two weeks to 40 adults with advanced soft tissue sarcoma that has not responded to standard treatments. The main goal is to see if the combination can shrink tumors safely. Researchers will also measure ho…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could adding immunotherapy to Pre-Sarcoma treatment boost survival?
Disease control Not yet recruitingThis study looks at whether adding an immunotherapy drug (penpulimab) to standard pre-surgery radiation and a targeted therapy (anlotinib) can help people with soft tissue sarcoma live longer without the cancer coming back. About 274 adults with intermediate- to high-grade sarcom…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New combo therapy aims to improve sarcoma surgery outcomes
Disease control Not yet recruitingThis trial is testing whether giving a special type of radiation (ultra-hypofractionated) along with immunotherapy before surgery is safe and feasible for people with retroperitoneal sarcoma. The study will enroll 28 participants. The main goal is to see how many patients have co…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThis phase 2 trial is testing a new treatment for soft tissue sarcoma that combines a special type of radiation with immunotherapy and immune-boosting drugs. The goal is to see if this combination can shrink tumors and improve outcomes for people with advanced or recurrent sarcom…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New cocktail of drugs and radiation targets Hard-to-Treat sarcoma
Disease control Not yet recruitingThis phase 2 trial tests a combination of the immunotherapy epalrotokewali, chemotherapy eribulin, targeted therapy anlotinib, and radiotherapy in 46 people with advanced soft tissue sarcoma that has progressed after prior treatment. The goal is to see if this mix can shrink tumo…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can tailored exercise help young sarcoma survivors recover strength?
Symptom relief Not yet recruitingThis study tests whether a personalized exercise program can improve physical function and quality of life in adolescents and young adults who have survived sarcoma. Participants first complete a triage tool to assess their needs, then receive a 12-week exercise plan that may inc…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Glow-in-the-dark dye may help surgeons spot sarcoma during removal
Knowledge-focused Not yet recruitingThis early-stage study tests whether a fluorescent dye called 5-ALA can make soft-tissue sarcoma tumors glow during surgery, helping surgeons see the edges more clearly. About 20 adults with grade 2 or 3 sarcoma will take the dye by mouth before their standard surgery. The main g…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC